American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1965)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (714)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (5)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1362)

Results (4047)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predicting molecular subtype and survival of rhabdomyosarcoma patients using deep learning of H&E images: A report from the Children's Oncology Group
    Journal Article

    Milewski, D.; Jung, H.; Brown, G. T.; Liu, Y.; Somerville, B.; Lisle, C.; Ladanyi, M.; Rudzinski, E. R.; Choo-Wosoba, H.; Barkauskas, D. A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer
    Journal Article

    Ashley, C. W.; Selenica, P.; Patel, J.; Wu, M.; Nincevic, J.; Lakhman, Y.; Zhou, Q.; Shah, R. H.; Berger, M. F.; Da Cruz Paula, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation
    Journal Article

    Shouval, R.; Waters, N. R.; Gomes, A. L. C.; Zuanelli Brambilla, C.; Fei, T.; Devlin, S. M.; Nguyen, C. L.; Markey, K. A.; Dai, A.; Slingerland, J. B.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Targeting non-canonical Hippo pathway in NRF2-mutant liver cancer
    Meeting Abstract

    Sanghvi, V.; Rust, A.; Leibold, J.; Lowe, S.; Viale, A.; Chodera, J.; Hendrickson, R. C.; de Stanchina, E.; Wendel, H. G.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Tepotinib efficacy and safety in patients with MET exon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Garassino, M. C.; Le, X.; Iam, W. T.; Felip, E.; Sakai, H.; Veillon, R.; Smit, E. F.; Mazieres, J.; Raskin, J.; Cortot, A. B.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Environmental factors associated with residual disease after ovarian cancer primary cytoreduction surgery
    Meeting Abstract

    Phung, M. T.; Berchuck, A.; Goode, E. L.; Goodman, M. T.; Hanley, G. E.; Richardson, J.; Grout, B.; Chase, A.; Deurloo, C. M.; Karlan, B. Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Variability in NTRK gene fusions does not appear to impact response to larotrectinib
    Meeting Abstract

    Ladanyi, M.; Roy-Chowdhuri, S.; Ritterhouse, L.; Sahm, F.; Norenberg, R.; Shen, K.; Chen, C.; Fellous, M.; Brega, N.; van Tilburg, C. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • The Clinical Genome Resource (ClinGen) somatic cancer clinical domain working group
    Meeting Abstract

    Saliba, J.; Raca, G.; Roy, A.; King, I.; Selvarajah, S.; Xu, X.; Kanagal-Shamanna, R.; Satgunaseelan, L.; Meredith, D.; Evans, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in solid tumors with defects in polymerase epsilon
    Meeting Abstract

    Rousseau, B.; Bieche, I.; Pasmant, E.; Hamzaoui, N.; Leulliot, N.; Michon, L.; de Reynies, A.; Foote, M.; Masliah-Planchon, J.; Svrcek, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 biomarker analyses
    Meeting Abstract

    Lei, M.; Janjigian, Y. Y.; Ajani, J. A.; Moehler, M.; Wang, X.; Shen, L.; Garrido, M.; Gallardo, C.; Yamaguchi, K.; Wyrwicz, L.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: